Aptamer Group wins GBP360,000 contract with global pharmaceutical company for radiopharmaceutical development

Oxford BioDynamics and UEA develop 96% accurate blood test for Chronic Fatigue Syndrome

Oncoinvent reports positive final Phase 1 results for Radspherin in ovarian cancer trial

Precision NeuroMed's glioblastoma multiforme treatment granted FDA Orphan Drug Designation

Oncoinvent reports positive Phase 1 Radspherin trial data

MaaT Pharma receives positive safety update for Phase 2b PHOEBUS trial of MaaT033

Daiichi Sankyo and AstraZeneca report positive phase 3 results for DATROWAY in metastatic triple negative breast cancer

Polarean expands Ascend Imaging partnership to boost US market reach

HanchorBio's HCB301 abstract accepted for poster presentation at SITC 2025 Annual Meeting

XenoSTART and Minerva Imaging expand partnership

INOVIO announces inducement grant to new employee

Jazz Pharmaceuticals' Zepzelca (lurbinectedin) and atezolizumab (Tecentriq) combination approved by FDA in ES-SCLC

Abbvie invests in US expansion

Genmab to acquire Merus in USD8bn all-cash deal

ANGLE presents proof-of-concept data on circulating tumour cells in glioblastoma